84 related articles for article (PubMed ID: 10368694)
1. Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas.
González-Aguilera JJ; Herrero MP; Maillo C; Moreno-Azcoita M; Fernández-Peralta AM
Anticancer Res; 1999; 19(2A):1325-9. PubMed ID: 10368694
[TBL] [Abstract][Full Text] [Related]
2. [Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma].
Zhou CZ; Zheng HT; Qiu GQ; Zhang F; He L; Peng ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1804-7. PubMed ID: 17054854
[TBL] [Abstract][Full Text] [Related]
3. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer.
Peng Z; Zhou C; Zhang F; Ling Y; Tang H; Bai S; Liu W; Qiu G; He L
Chin Med J (Engl); 2002 Oct; 115(10):1529-32. PubMed ID: 12490103
[TBL] [Abstract][Full Text] [Related]
5. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.
Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W
J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705
[TBL] [Abstract][Full Text] [Related]
7. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
Prall F; Weirich V; Ostwald C
Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
[TBL] [Abstract][Full Text] [Related]
8. [Refined deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal carcinoma].
Zheng HT; Tang HM; Peng ZH; Zhou CZ; He L
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):157-60. PubMed ID: 16555160
[TBL] [Abstract][Full Text] [Related]
9. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
Purdie CA; Piris J; Bird CC; Wyllie AH
J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.
Jernvall P; Mäkinen MJ; Karttunen TJ; Mäkelä J; Vihko P
Br J Cancer; 1999 Feb; 79(5-6):903-8. PubMed ID: 10070888
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
[TBL] [Abstract][Full Text] [Related]
12. [Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma].
Peng Z; Ling Y; Bai S
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):336-9. PubMed ID: 11798895
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
[TBL] [Abstract][Full Text] [Related]
14. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
Matsuzaki K; Deng G; Tanaka H; Kakar S; Miura S; Kim YS
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8564-9. PubMed ID: 16361538
[TBL] [Abstract][Full Text] [Related]
15. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
16. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite analysis of fecal DNA for colorectal cancer detection.
Koshiji M; Yonekura Y; Saito T; Yoshioka K
J Surg Oncol; 2002 May; 80(1):34-40. PubMed ID: 11967905
[TBL] [Abstract][Full Text] [Related]
19. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
[TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity analysis to define putative region involved in tumor differentiation and metastases in sporadic colorectal cancer patients].
Peng Z; Zhang F; Zhou C; Qiu G; Bai S; Liu W; He L
Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):776-9. PubMed ID: 12487884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
